Reuters logo
BRIEF-CRISPR and Casebia collaborate with CureVac on mRNA for gene-editing programs
2017年11月13日 / 下午12点34分 / 11 天前

BRIEF-CRISPR and Casebia collaborate with CureVac on mRNA for gene-editing programs

Nov 13 (Reuters) - CRISPR Therapeutics AG

* CRISPR Therapeutics and Casebia collaborate with CureVac on mRNA for gene-editing programs

* ‍Under terms, CureVac will develop novel Cas9 mRNA constructs with improved properties for gene editing applications​

* ‍In exchange, CureVac will receive an upfront payment and research funding ​

* CRISPR Therapeutics-‍CureVac to also be eligible to receive development, commercial milestones, royalties on commercialized products from collaboration​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below